Vaipa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 08-12-2024
- Paid Up Capital ₹ 6.50 M
as on 08-12-2024
- Company Age 39 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 82.14%
(FY 2020)
- Ebitda 98.03%
(FY 2020)
- Net Worth -0.03%
(FY 2020)
- Total Assets -1.25%
(FY 2020)
About Vaipa Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 6.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neepa Parikh and Jinesh Parikh serve as directors at the Company.
- CIN/LLPIN
U21039MH1985PTC035199
- Company No.
035199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaipa Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neepa Parikh  | Director | 12-Jan-2011 | Current |
| Jinesh Parikh | Director | 02-Mar-2009 | Current |
Financial Performance and Corporate Structure Insights of Vaipa Pharmaceuticals.
Vaipa Pharmaceuticals Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 82.14% increase in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaipa Pharmaceuticals?
In 2019, Vaipa Pharmaceuticals had a promoter holding of 98.16% and a public holding of 1.85%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Njp Healthcare Private LimitedActive 12 years 11 monthsNeepa Parikh and Jinesh Parikh are mutual person
Leopard Investments Pvt LtdActive 35 years 10 monthsNeepa Parikh and Jinesh Parikh are mutual person
- Vrushal Trading Private LimitedActive 35 years 1 day
Neepa Parikh and Jinesh Parikh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaipa Pharmaceuticals?
Unlock and access historical data on people associated with Vaipa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaipa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaipa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
